Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

Transfusion(2023)10.1111/trf.17485Source: DataRank Database

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials is a research paper published in Transfusion (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 2.02)OA: hybridTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (58)

Jay S. Raval ORCID,James H. Paxton ORCID,Giselle Mosnaim ORCID,Bela Patel ORCID,Shweta Anjan ORCID

Live enrichment

PubMed:37534607 PMC:PMC10720768 OpenAlex:https://openalex.org/W4385514459

National Center for Advancing Translational Sciences

Grant: U24TR001609

National Institute of Allergy and Infectious Diseases

Grant: 3R01AI152078‐01S1

National Institute on Drug Abuse

Grant: F31DA054849

U.S. Department of Defense

Grant: W911QY2090012

NCATS NIH HHS

Grant: UL1 TR003098

NIAID NIH HHS

Grant: R01 AI120938

NIAID NIH HHS

Grant: R01 AI152078

NCATS NIH HHS

Grant: UL1 TR001409

NCATS NIH HHS

Grant: UM1 TR004409

Octapharma

Shear Family Foundation

FWCI

2.02

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17485

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/trf.17485

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17485

journalhttps://doi.org/10.1111/trf.17485

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37534607

Fields of Study

Blood groups and transfusionBlood transfusion and managementSARS-CoV-2 and COVID-19 ResearchHumansCOVID-19COVID-19 SerotherapyImmunization, PassiveOutpatientsSARS-CoV-2Transfusion ReactionUrticariaRandomized Controlled Trials as Topic

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyHumansImmunization, PassiveOutpatientsUrticariaRandomized Controlled Trials as TopicTransfusion Reaction

Keywords

MedicineOdds ratioBlood transfusionAdverse effectClinical trialAmbulatoryConfoundingInternal medicineDiseaseRandomized controlled trialConvalescent plasmaCoronavirus disease 2019 (COVID-19)Logistic regressionIntensive care medicineEmergency medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being